RESMvsGSSCETF Comparison
VS
ETF 2
GSSC
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
This fund is part of
US Multi-Factor
+0.49%
Columbia Research Enhanced Small Cap ETF (RESM) and Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF (GSSC) belong to the same industry segment: US Multi-Factor. Both ETFs have the same top 3 sector exposures: Finance, Healthcare and Technology. RESM is more expensive with a Total Expense Ratio (TER) of 0.32%, versus 0.2% for GSSC. RESM is up 19.74% year-to-date (YTD) with +$397K in YTD flows. GSSC performs worse with 18.17% YTD performance, and +$207M in YTD flows. Run a side-by-side ETF comparison of RESM and GSSC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
RESM vs GSSC performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/29/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | RESM GSSC | +3.57%+2.96% | -0.08%+0.19% | +19.74%+18.17% | n/a+19.62% | n/a+76.55% | n/a+44.13% |
| Flows | RESM GSSC | -- | +$2M+$40M | +$397K+$207M | -+$232M | -+$317M | -+$405M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | RESM GSSC | +12.18%+12.96% | n/a+16.95% | n/a+20.33% | n/a+21.30% |
| Max drawdown | RESM GSSC | -9.03%-8.65% | n/a-10.69% | n/a-25.99% | n/a-27.32% |
| Max drawdown duration | RESM GSSC | 74d74d | n/a84d | n/a289d | n/a977d |
Trading data
RESM | GSSC | |
Last sale 10/30/2026 at 1:30 PM | $23.46 | $87.33 |
| Previous close 10/29/2026 | $23.80 | $88.66 |
| Consolidated volume 10/29/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
RESM
is actively managed and doesn’t replicate an indexRESM | GSSC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/30/2026 at 1:30 PM
Live
Closed
RESM | GSSC | |
|---|---|---|
| Last price | $23.46 | $87.33 |
| 1D performance | -1.41% | -1.50% |
| AuM | $5.96 M | $1.08 B |
| E/R | 0.32% | 0.2% |
Characteristics
RESM | GSSC | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Columbia Threadneedle Investments | Goldman Sachs |
| Benchmark | - | Goldman Sachs ActiveBeta U.S. Small Cap Equity Index |
| N° of holdings | 998 | 1354 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 11, 2025 | June 28, 2017 |
| ESG | No | No |
Advertisement
Exposure
Countries
RESM
USA
94.21%
Other
5.79%
GSSC
USA
92.63%
Other
7.37%
Sectors
RESM
Finance
24.29%
Healthcare
19.31%
Technology
14.58%
Industrials
9.87%
Energy
7.02%
Other
24.93%
GSSC
Finance
24.48%
Healthcare
22.69%
Technology
13.05%
Industrials
8.36%
Other
31.42%
Diversification
RESM
Total weight of top 15 holdings out of 15
7.17%
GSSC
Total weight of top 15 holdings out of 15
4.9%
Top 15 holdings
Data as of September 30, 2026
RESM
Columbia Short Term Cash Fund
0.63%
JFrog Ltd.
0.58%
UMB Financial Corp.
0.50%
Moog, Inc.
0.50%
ViaSat, Inc.
0.49%
BrightSpring Health Services, Inc.
0.48%
InterDigital, Inc.
0.47%
FirstCash Holdings, Inc.
0.46%
Glaukos Corp.
0.45%
Old National Bancorp
0.45%
10X Genomics, Inc.
0.44%
MaxLinear, Inc.
0.44%
CareTrust REIT, Inc.
0.44%
Oscar Health, Inc.
0.43%
Zeta Global Holdings Corp.
0.41%
GSSC
10X Genomics, Inc.
0.66%
CareDx, Inc.
0.50%
Travere Therapeutics, Inc.
0.34%
Acadian Asset Management, Inc.
0.34%
Alkermes Plc
0.32%
AtriCure, Inc.
0.31%
StoneX Group, Inc.
0.29%
Zeta Global Holdings Corp.
0.29%
Enova International, Inc.
0.28%
TG Therapeutics, Inc.
0.27%
Victoria's Secret & Co.
0.26%
UMB Financial Corp.
0.26%
Amneal Pharmaceuticals, Inc.
0.26%
ViaSat, Inc.
0.26%
Ligand Pharmaceuticals, Inc.
0.26%
Frequently asked questions about RESM and GSSC
How have the RESM and GSSC ETFs performed in 2026?
As of October 29, 2026, RESM is up 19.74% year-to-date (YTD), while GSSC has returned 18.17%. That puts RESM better performer ahead so far this year.
Which ETF is attracting more investor money: RESM or GSSC?
Year-to-date, the RESM ETF saw +$397K in flows, compared to +$207M for GSSC.
Which ETF is bigger: RESM or GSSC?
As of October 29, 2026, RESM holds $5.96 M in assets under management (AUM), while GSSC manages $1.08 B.
What sectors do the RESM and GSSC ETFs invest in?
RESM leans toward sectors like Finance, Healthcare and Technology. Meanwhile, GSSC focuses on Finance, Healthcare and Technology.
What are the top holdings of the RESM ETF and GSSC ETF?
RESM top holdings include Columbia Short Term Cash Fund, JFrog Ltd. and UMB Financial Corp.. GSSC holds in its top three: 10X Genomics, Inc., CareDx, Inc. and Travere Therapeutics, Inc..
Which ETF is more diversified: RESM or GSSC?
RESM holds 1001 securities with 7.17% of its assets in the top 15. GSSC has 1360 securities and a top 15 weight of 4.9%.
Advertisement
Advertisement
